COM:NEUROCRINE
Neurocrine Biosciences
- Stock
Last Close
125.00
22/11 21:00
Market Cap
13.71B
Beta: -
Volume Today
1.18M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -46.09M - | -60.54M 31.36% | -88.93M 46.89% | -141.09M 58.65% | -142.54M 1.03% | 21.11M 114.81% | 37.01M 75.32% | 407.30M 1,000.45% | 89.60M 78.00% | 154.50M 72.43% | 249.70M 61.62% | |
depreciation and amortization | 671K - | 827K 23.25% | 1.01M 22.01% | 1.45M 44.00% | 2.40M 65.18% | 4.02M 67.67% | 7.45M 85.19% | 8.60M 15.41% | 10.90M 26.74% | 15.60M 43.12% | 21.30M 36.54% | |
deferred income tax | -327K - | 570K 274.31% | 2.70M 373.33% | 89K 96.70% | -348K 491.01% | 689K 297.99% | 11.02M 1,499.71% | -310.70M 2,918.91% | 4.30M 101.38% | 19.10M 344.19% | -56.70M 396.86% | |
stock based compensation | 6.82M - | 10.38M 52.25% | 28.39M 173.47% | 28.46M 0.25% | 42.52M 49.39% | 58.07M 36.56% | 75.26M 29.61% | 100M 32.87% | 134.20M 34.20% | 173.10M 28.99% | 194.30M 12.25% | |
change in working capital | 12.10M - | 1.61M 86.70% | 8.70M 440.89% | 5.78M 33.57% | -8.81M 252.34% | -1.76M 80.05% | 241K 113.72% | -37.90M 15,826.14% | 16.70M 144.06% | -67.40M 503.59% | 28.20M 141.84% | |
accounts receivables | 13.53M - | -1.67M 112.35% | -489K 70.74% | 1.79M 466.26% | -31.13M 1,837.97% | -25.11M 19.32% | -69.17M 175.43% | -30.50M 55.91% | -28.40M 6.89% | -162.20M 471.13% | -89.30M 44.94% | |
inventory | -39K - | -108K 176.92% | -1.02M 848.15% | -3.52M 244.14% | -6.42M 82.29% | -10.70M 66.56% | -2.50M 76.64% | -2.60M 4% | 5.40M 307.69% | |||
accounts payables | 3.70M - | 9.84M 166.12% | 4.40M 55.31% | 27.34M 521.60% | 18.18M 33.50% | 53.95M 196.80% | 26.90M 50.14% | 56.80M 111.15% | 114.60M 101.76% | 64.30M 43.89% | ||
other working capital | -1.43M - | -418K 70.79% | -610K 45.93% | -300K 50.82% | -3.99M 1,231.33% | 8.70M 317.85% | 21.88M 151.45% | -23.60M 207.87% | -9.20M 61.02% | -17.20M 86.96% | 47.80M 377.91% | |
other non cash items | -2.78M - | 14K 100.50% | 10.13M 72,257.14% | -878K 108.67% | 12.44M 1,517.31% | 19.23M 54.52% | 21.07M 9.55% | 61.20M 190.53% | 800K 98.69% | 44.50M 5,462.50% | -46.90M 205.39% | |
net cash provided by operating activities | -29.61M - | -47.14M 59.22% | -38.00M 19.40% | -106.18M 179.45% | -94.33M 11.16% | 101.36M 207.46% | 152.05M 50.01% | 228.50M 50.28% | 256.50M 12.25% | 339.40M 32.32% | 389.90M 14.88% | |
investments in property plant and equipment | -545K - | -1.61M 195.78% | -1.93M 19.98% | -4.11M 112.41% | -6.94M 68.94% | -24.81M 257.52% | -14.75M 40.56% | -10.90M 26.09% | -23.40M 114.68% | -16.50M 29.49% | -28.30M 71.52% | |
acquisitions net | 40K - | 45K 12.50% | 9K 80% | 13K 44.44% | 7K 46.15% | 8K - | 0.00 100.00% | 4.60M 987,842,478,080,000,000% | -42.70M 1,028.26% | 31.30M 173.30% | ||
purchases of investments | -145.33M - | -257.54M 77.22% | -449.05M 74.36% | -298.78M 33.47% | -583.41M 95.27% | -545.96M 6.42% | -797.17M 46.01% | -735.50M 7.74% | -804.70M 9.41% | -628.90M 21.85% | -1.41B 124.39% | |
sales maturities of investments | 151.28M - | 154.13M 1.89% | 255.12M 65.52% | 415.83M 62.99% | 339.09M 18.45% | 327.82M 3.32% | 669.69M 104.28% | 750.50M 12.07% | 697.90M 7.01% | 511M 26.78% | 972.40M 90.29% | |
other investing activites | -108K - | -388K 259.26% | 40K 110.31% | -92K 330% | 383K 516.30% | 34K 91.12% | -68.86M 202,614.71% | -4.60M - | -31.30M - | |||
net cash used for investing activites | 5.34M - | -105.37M 2,073.15% | -195.81M 85.84% | 112.86M 157.64% | -250.87M 322.28% | -242.91M 3.17% | -211.07M 13.11% | 4.10M 101.94% | -130.20M 3,275.61% | -177.10M 36.02% | -467.10M 163.75% | |
debt repayment | -186.90M - | -100K 99.95% | -279M 278,900% | |||||||||
common stock issued | 5.30M - | 138.73M 2,516.58% | 276.99M 99.66% | 2.39M 99.14% | 13.87M 480.13% | 29.53M 112.98% | 27.31M 7.51% | 29.10M 6.54% | 27.50M 5.50% | 44.70M 62.55% | 65.30M 46.09% | |
common stock repurchased | ||||||||||||
dividends paid | ||||||||||||
other financing activites | 502.78M - | 32.40M - | -157.80M 587.04% | |||||||||
net cash used provided by financing activities | 5.30M - | 138.73M 2,516.58% | 276.99M 99.66% | 2.39M 99.14% | 516.65M 21,516.99% | 29.53M 94.28% | 27.31M 7.51% | -157.80M 677.75% | 27.40M 117.36% | -234.30M 955.11% | 65.30M 127.87% | |
effect of forex changes on cash | -1.30M - | 300K 123.08% | ||||||||||
net change in cash | -18.96M - | -13.78M 27.37% | 43.18M 413.47% | 9.07M 78.99% | 171.44M 1,789.83% | -112.02M 165.34% | -31.71M 71.70% | 74.80M 335.92% | 153.70M 105.48% | -73.30M 147.69% | -11.60M 84.17% | |
cash at beginning of period | 63.75M - | 44.79M 29.75% | 31.01M 30.76% | 74.19M 139.23% | 83.27M 12.23% | 259.21M 211.30% | 147.19M 43.22% | 115.50M 21.53% | 190.30M 64.76% | 344M 80.77% | 270.70M 21.31% | |
cash at end of period | 44.79M - | 31.01M 30.76% | 74.19M 139.23% | 83.27M 12.23% | 254.71M 205.90% | 147.19M 42.21% | 115.48M 21.54% | 190.30M 64.78% | 344M 80.77% | 270.70M 21.31% | 259.10M 4.29% | |
operating cash flow | -29.61M - | -47.14M 59.22% | -38.00M 19.40% | -106.18M 179.45% | -94.33M 11.16% | 101.36M 207.46% | 152.05M 50.01% | 228.50M 50.28% | 256.50M 12.25% | 339.40M 32.32% | 389.90M 14.88% | |
capital expenditure | -545K - | -1.61M 195.78% | -1.93M 19.98% | -4.11M 112.41% | -6.94M 68.94% | -24.81M 257.52% | -14.75M 40.56% | -10.90M 26.09% | -23.40M 114.68% | -16.50M 29.49% | -28.30M 71.52% | |
free cash flow | -30.15M - | -48.75M 61.69% | -39.93M 18.09% | -110.29M 176.20% | -101.27M 8.18% | 76.55M 175.59% | 137.31M 79.36% | 217.60M 58.48% | 233.10M 7.12% | 322.90M 38.52% | 361.60M 11.99% |
All numbers in USD (except ratios and percentages)